IGF1R and Graves disease: We confirmed that diosgenin can bind to IGF-1R and inhibit the activation of Akt and ERK pathways by inhibiting the phosphorylation of IGF-1R, resulting in increasing apoptosis of hyperproliferated thyroid cells in Graves’ disease and alleviating goiter.